<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="363069">
  <stage>Registered</stage>
  <submitdate>27/09/2012</submitdate>
  <approvaldate>28/09/2012</approvaldate>
  <actrnumber>ACTRN12612001042831</actrnumber>
  <trial_identification>
    <studytitle>Evaluating the efficacy of an integrated smoking cessation intervention for mental health patients: a randomised controlled trial.</studytitle>
    <scientifictitle>Evaluating the efficacy of an integrated smoking cessation intervention for mental health patients: a randomised controlled trial.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Pilot registration ID: ACTRN12609000465257</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Smoking</healthcondition>
    <healthcondition>Mental health</healthcondition>
    <conditioncode>
      <conditioncode1>Public Health</conditioncode1>
      <conditioncode2>Other public health</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Addiction</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>In inpatient setting:
- 10-15 minute motivational interview
- 3 quit smoking pamphlets tailored to people with mental illness

On discharge:
NRT discharge pack

In the community:
- Up to 12 weeks provision of Nicotine Replacement Therapy (NRT), including patches, gum, lozenges, inhalers and oral spray
- 16 weeks of telephone support. These will be delivered weekly between weeks 1 and 4, weekly or fortnightly (participant preference) between weeks 5 and 12, and fortnightly between weeks 12 and 16.
- Proactive referral to Quitline
- A one page letter to participants general practitioners (GP) and other mental health professionals outlining their clients participation the study.</interventions>
    <comparator>Control group will receive standard hospital care for treatment of smoking. This care may entail provision of nicotine replacement therapy (NRT), including gum, lozenges, inhalers and patches continuously for the duration of the hospital stay. Upon discharge, patients may be given the option to receive an active referral to Quitline, and 3 days supply of 21mg/24 hour patches.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Abstinence from smoking (both point prevalence and  continuous) assessed via self-report with biochemical verification (CO).</outcome>
      <timepoint>All participants will be followed up via telephone survey at 1, 6 and 12 months post discharge.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Changes in smoking behavior, including reduction in daily cigarette consumption, number and duration of quit attempts, and readiness to quit. Detailed process data will also be collected, these include the uptake and use of smoking cessation supports.   </outcome>
      <timepoint>All participants will be followed up via telephone survey at 1, 6 and 12 months post discharge.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>- individual admitted to mental health inpatient facility
- smokes cigarettes
- capacity to give informed consent
- can provide contact details to facilitate communication post discharge. </inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Non-smoker</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3>True</masking3>
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>11/10/2012</anticipatedstartdate>
    <actualstartdate>16/10/2012</actualstartdate>
    <anticipatedenddate>30/04/2014</anticipatedenddate>
    <actualenddate>30/04/2014</actualenddate>
    <samplesize>800</samplesize>
    <actualsamplesize>754</actualsamplesize>
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>2430</postcode>
    <postcode>2298</postcode>
    <postcode>2320</postcode>
    <postcode>2348</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Newcastle</primarysponsorname>
    <primarysponsoraddress>University Drive
Callaghan NSW 2308</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>National Health and Medical Research Council</fundingname>
      <fundingaddress>Level 1
16 Marcus Clarke Street
Canberra ACT 2601</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Government body</sponsortype>
      <sponsorname>Hunter New England Population Health</sponsorname>
      <sponsoraddress>Longworth Ave, Wallsend, NSW 2287, Australia</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The efficacy of a smoking cessation intervention initiated during a mental health hospital admission and continued post discharge will be assessed via randomised controlled trial. At 12 months post-test, it is hypothesised that participants receiving the intervention will have a 10% points higher 7-day point prevalence abstinence from smoking (20%) as compared to participants that did not (10%), and a 4% points higher prevalence of prolonged abstinence (5%, as compared to 1%).</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Hunter New England Research Ethics Committee</ethicname>
      <ethicaddress>Hunter New England Health Research Ethics Unit
Administration Building
Lookout Road
New Lambton   NSW   2305</ethicaddress>
      <ethicapprovaldate>15/02/2012</ethicapprovaldate>
      <hrec>11/12/14/4.02</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>University of Newcastle Human Research Ethics Committee</ethicname>
      <ethicaddress>University Drive, Callaghan, NSW 2308, Australia</ethicaddress>
      <ethicapprovaldate>10/12/2012</ethicapprovaldate>
      <hrec>H-2012-0061</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Jenny Bowman</name>
      <address>School of Psychology
University of Newcastle, 
University Drive, 
Callaghan NSW 2308</address>
      <phone>+61 2 49215958</phone>
      <fax>+ 612 4921 6980</fax>
      <email>jenny.bowman@newcastle.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Jenny Bowman</name>
      <address>School of Psychology
University of Newcastle, 
University Drive, 
Callaghan NSW 2308</address>
      <phone>+61 2 49215958</phone>
      <fax>+ 612 4921 6980</fax>
      <email>jenny.bowman@newcastle.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Ms</title>
      <name>Alexandra Metse</name>
      <address>School of Psychology
University of Newcastle, 
University Drive, 
Callaghan NSW 2308</address>
      <phone>02 49 21 7781</phone>
      <fax>+ 612 4921 6980</fax>
      <email>Alexandra.metse@uon.edu.au </email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Jenny Bowman</name>
      <address>School of Psychology University of Newcastle, University Drive, Callaghan NSW 2308</address>
      <phone>+61 2 49215958</phone>
      <fax />
      <email>jenny.bowman@newcastle.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>